Shinichiro Okamoto

12.3k citations

389 papers · 7.1k indexed · 1 hit paper · h-index 41

Hematology top 0.1%
- Hematopoietic Stem Cell Transplantation 108
- Acute Myeloid Leukemia Research 65
- Chronic Myeloid Leukemia Treatments 50
Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 42
Transplantation top 1%
Oncology top 2%
- Polyomavirus and related diseases 25
Immunology top 2%
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 43
Pathology and Forensic Medicine
- Lymphoma Diagnosis and Treatment 29
Rheumatology
- Eosinophilic Disorders and Syndromes 28

Co-authors: Takehiko Mori Yasuo Ikeda Yoko Ogawa Kazuo Tsubota Hisashi Sakamaki Yoshinobu Aisa Yoshinobu Kanda Takayuki Shimizu
Cited by: Hematology Genetics Transplantation
Journals: Nature (1 paper)Journal of Biological Chemistry (1 paper)Journal of Clinical Investigation (1 paper)
Partner nations: Japan United States United Kingdom

In The Last Decade

Shinichiro Okamoto

371 papers receiving 7.0k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Shinichiro Okamoto

Since Specialization

Citations

This map shows the geographic impact of Shinichiro Okamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinichiro Okamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinichiro Okamoto more than expected).

Fields of papers citing papers by Shinichiro Okamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinichiro Okamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinichiro Okamoto. The network helps show where Shinichiro Okamoto may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shinichiro Okamoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shinichiro Okamoto Line = papers co-authored together Shinichiro Okamoto links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Adeno-associated virus expressing a blood-brain barrier–penetrating enzyme improves GM1 gangliosidosis in a preclinical model Journal of Clinical Investigation ·S. Matsushima,Yohta Shimada,Masafumi Kinoshita,Takashi Nagashima,Shinichiro Okamoto,Sayoko Iizuka,Haruna Takagi,Shunsuke Iizuka,Takashi Higuchi,Hiroyuki Hioki,Ayako M. Watabe,Hiroyuki Sonoda,Toya Ohashi,Hiroshi Kobayashi	2025	0
2	Distinct roles of the preparatory and payoff phases of glycolysis in hematopoietic stem cells Experimental Hematology ·Kohei Shiroshita,Hiroshi Kobayashi,S. Watanuki,Daiki Karigane,Yuriko Sorimachi,Shinpei Tamaki,Miho Haraguchi,Masamichi Yamamoto,Ayako Nakamura‐Ishizu,Shinichiro Okamoto,Keisuke Kataoka,Keiyo Takubo	2023	4
3	American Society of Transplantation and Cellular Therapy International Affair Committee: Report of the Third Workshop on Global Perspective to Access to Transplantation at the 2022 Tandem Meeting Transplantation and Cellular Therapy ·Shinichiro Okamoto,Minako Iida,Nada Hamad,Fernando Barroso Duarte,Anna Sureda,Alok Srivastava,Sebastián Galeano,Nelson J. Chao,Damiano Rondelli,Mary E.D. Flowers	2023	2
4	Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria Annals of Hematology ·Hubert Schrezenmeier,Austin Kulasekararaj,Lindsay Mitchell,Régis Peffault de Latour,Timothy Devos,Shinichiro Okamoto,Richard A. Wells,Evan Popoff,Antoinette Cheung,Alice Wang,Ioannis Tomazos,Yogesh Patel,Jong Wook Lee	2023	6
5	Establishment of a Cellular Therapy Registry in Japan, a platform for data sharing for research, industry, and regulatory use Yoshiko Atsuta,Shinichiro Okamoto,Takanori Teshima	2022	0
6	Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: post-marketing surveillance in Japan International Journal of Hematology ·Takayuki Ikezoe,Hideyoshi Noji,Yasutaka Ueda,Yoshinobu Kanda,Shinichiro Okamoto,Kensuke Usuki,Takahisa Matsuda,H Akiyama,Akihiko Shimono,Yuji Yonemura,Tatsuya Kawaguchi,Shigeru Chiba,Yuzuru Kanakura,Jun‐ichi Nishimura,Haruhiko Ninomiya,Naoshi Obara	2022	8
7	Hemostatic function of cold‐stored platelets in a thrombocytopenic rabbit bleeding model Transfusion ·Masayuki Nogawa,Naohide Watanabe,Toshiyasu Koike,Kanae Fukuda,Mariko Ishiguro,Hitomi Fujino,Junichi Hirayama,Masayuki Shiba,Makoto Handa,Takehiko Mori,Shinichiro Okamoto,Shigeki Miyata,Masahiro Satake	2022	3
8	Off-the-shelf bone marrow-derived mesenchymal stem cell treatment for acute graft-versus-host disease: real-world evidence Bone Marrow Transplantation ·Makoto Murata,Seitaro Terakura,Atsushi Wake,Kotaro Miyao,Kazuhiro Ikegame,Naoyuki Uchida,Keisuke Kataoka,Toshihiro Miyamoto,Makoto Onizuka,Tetsuya Eto,Noriko Doki,Shuichi Ota,Maho Sato,Yoshiko Hashii,Tatsuo Ichinohe,Takahiro Fukuda,Yoshiko Atsuta,Shinichiro Okamoto,Takanori Teshima	2021	33
9	The Inhibitor of Apoptosis Protein Livin Confers Resistance to Fas-Mediated Immune Cytotoxicity in Refractory Lymphoma Cancer Research ·Eiji Sugihara,Norisato Hashimoto,Satoru Osuka,Takatsune Shimizu,Sayaka Ueno,Shogo Okazaki,Tomonori Yaguchi,Yutaka Kawakami,Kenjiro Kosaki,Taka-Aki Sato,Shinichiro Okamoto,Hideyuki Saya	2020	10
10	Megakaryocytes and platelets from a novel human adipose tissue–derived mesenchymal stem cell line Blood ·Keiichi Tozawa,Yukako Ono‐Uruga,Masaki Yazawa,Taisuke Mori,Mitsuru Murata,Shinichiro Okamoto,Yasuo Ikeda,Yumiko Matsubara	2018	35
11	Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia with Pre-Transplant Conditioning Using Fludarabine, Reduced-Dose Cyclophosphamide, and Low-Dose Thymoglobulin:Â Ksgct Prospective Study Blood ·Shinichi Kako,Yoshinobu Kanda,Makoto Onizuka,Nobuyuki Aotsuka,Kensuke Usuki,Takayoshi Tachibana,Takeshi Kobayashi,Jun Kato,Shingo Yano,Hiroaki Shimizu,Katsuhiro Shono,Masatsugu Tanaka,Shokichi Tsukamoto,Takehiko Mori,Etsuko Yamazaki,Shinichiro Okamoto	2018	0
12	Single-institutional retrospective analysis of Japanese patients with chronic lymphocytic leukemia. PubMed ·Risa Hashida,Sumiko Kohashi,Jun Kato,Taku Kikuchi,Masatoshi Sakurai,Takaaki Toyama,Yuya Koda,Yusuke Yamane,Ryohei Abe,Takayuki Shimizu,Rie Yamazaki,Takayuki Mitsuhashi,Mitsuru Murata,Shinichiro Okamoto,Takehiko Mori	2017	1
13	International ITP Registry with Focus on the Asia Pacific Region: Update on Preliminary Findings of Epidemiological and Clinical Data Blood ·Beng H. Chong,Jong‐Wook Lee,Jun Ho Jang,Tzeon‐Jye Chiou,Lai Heng Lee,Osman İlhan,Pantep Angchaisuksiri,Ai‐Sim Goh,Soo Chin Ng,Shinichiro Okamoto,Kenny Gálvez,Sarah Davidson	2017	1
14	ITP Patients in the Asia Pacific: Are They Different? Blood ·Beng H. Chong,Jong‐Wook Lee,Jun Ho Jang,Tzeon‐Jye Chiou,Lai Heng Lee,Osman İlhan,Pantep Angchaisuksiri,Kenny Gálvez,Ai‐Sim Goh,Soo Chin Ng,Shinichiro Okamoto,Sarah Davidson	2017	0
15	Impact of the Duration of Methotrexate Administration and the Specific HLA Alleles on the Regressive Methotrexate-Induced Lymphoproliferative Disorders Blood ·Michihide Tokuhira,Shuntaro Saito,Ayumi Okuyama,Katsuya Suzuki,Morihiro Higashi,Shuju Momose,Takayuki Shimizu,Takehiko Mori,Tomoe Anan-Nemoto,Koichi Amano,Shinichiro Okamoto,Tsutomu Takeuchi,Jun‐ichi Tamaru,Masahiro Kizaki	2017	1
16	Induction of functional platelets from mouse and human fibroblasts by p45NF-E2/Maf Blood ·Yukako Ono,Yuhuan Wang,Hidenori Suzuki,Shinichiro Okamoto,Yasuo Ikeda,Mitsuru Murata,Mortimer Poncz,Yumiko Matsubara	2012	63
17	Identification of Loss of p16 Expression and Upregulation of MDR-1 as Genetic Events Resulting from Two Novel Chromosomal Translocations Found in a Plasmablastic Lymphoma of the Uterus Clinical Cancer Research ·Eri Matsuki,Yoshitaka Miyakawa,Shuichi Asakawa,Yuiko Tsukada,Taketo Yamada,Kenji Yokoyama,Jun Kudoh,Yasuo Ikeda,Shinichiro Okamoto	2011	10
18	Granisetron Plus Dexamethasone Versus Granisetron Alone in the Prevention of Vomiting Induced by Conditioning for Stem Cell Transplantation: A prospective Randomized Study International Journal of Hematology ·Sahoko Matsuoka,Shinichiro Okamoto,Rieko Watanabe,Takehiko Mori,Hitomi Nagayama,Yasuharu Hamano,Kenji Yokoyama,Nobuyuki Takayama,Yasuo Ikeda	2003	15
19	Ex vivo manipulation of umbilical cord blood-derived hematopoietic stem/progenitor cells with recombinant human stem cell factor can up-regulate levels of homing-essential molecules to increase their transmigratory potential Experimental Hematology ·Yizhou Zheng,Nobukazu Watanabe,Tokiko Nagamura‐Inoue,Koichi Igura,Hitomi Nagayama,Arinobu Tojo,Ryuji Tanosaki,Yoichi Takaue,Shinichiro Okamoto,Tsuneo Takahashi	2003	43
20	The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno‐occlusive disease after stem cell transplantation American Journal of Hematology ·Kazuteru Ohashi,Juichi Tanabe,Reiko Watanabe,Takeshi Tanaka,Hisashi Sakamaki,Atsuo Maruta,Shinichiro Okamoto,Nobuyuki Aotsuka,Kenji Saito,Miki Nishimura,Hakumei Oh,Michio Matsuzaki,Satoshi Takahashi,Shuji Yonekura	2000	4

About Shinichiro Okamoto

Shinichiro Okamoto is a scholar working on Hematology, Genetics and Transplantation, having authored 389 papers that have together received 7.1k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (108 papers), Acute Myeloid Leukemia Research (65 papers), Chronic Myeloid Leukemia Treatments (50 papers), Acute Lymphoblastic Leukemia research (43 papers), Chronic Lymphocytic Leukemia Research (42 papers), Lymphoma Diagnosis and Treatment (29 papers), Eosinophilic Disorders and Syndromes (28 papers) and Polyomavirus and related diseases (25 papers). The work is most often cited by research in Hematology (3.3k citations), Genetics (1.3k citations) and Transplantation (276 citations). Shinichiro Okamoto has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Takehiko Mori, Yasuo Ikeda, Yoko Ogawa, Kazuo Tsubota, Hisashi Sakamaki, Yoshinobu Aisa, Yoshinobu Kanda, Takayuki Shimizu, Jun Kato and Yoshiko Atsuta. Their work appears in journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact